Nabriva Therapeutics plc Proceeds from Stock Options Exercised
Nabriva Therapeutics plc reported Proceeds from Stock Options Exercised of $83.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2020-03-12
- Nabriva Therapeutics plc proceeds from stock options exercised for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Nabriva Therapeutics plc proceeds from stock options exercised for the quarter ending 2017-09-30 was $72.00K, a 1100.00% increase year-over-year.
- Nabriva Therapeutics plc proceeds from stock options exercised for the quarter ending 2017-06-30 was $1.00K, a 99.52% decline year-over-year.
- Nabriva Therapeutics plc proceeds from stock options exercised for the quarter ending 2017-03-31 was $10.00K, a 65.52% decline year-over-year.
- Nabriva Therapeutics plc proceeds from stock options exercised for fiscal 2017 was $83.00K, a 69.14% decline from fiscal 2016.
- Nabriva Therapeutics plc proceeds from stock options exercised for fiscal 2016 was $269.00K, a 5280.00% increase from fiscal 2015.
- Nabriva Therapeutics plc proceeds from stock options exercised for fiscal 2015 was $5.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $72.00K derived: sum of 2 quarters · filed 2020-03-12 | $73.00K derived: sum of 3 quarters · filed 2020-03-12 | $83.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $73.00K derived: sum of 2 quarters · filed 2018-11-06 | $83.00K 10-Q · filed 2018-11-06 | $109.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $11.00K 10-Q · filed 2018-08-09 | $37.00K derived: sum of 3 quarters · filed 2019-03-12 | $43.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $10.00K 10-Q · filed 2018-05-08 | $36.00K derived: sum of 2 quarters · filed 2019-03-12 | $42.00K derived: sum of 3 quarters · filed 2019-03-12 | $250.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $32.00K derived: sum of 2 quarters · filed 2019-03-12 | $240.00K derived: sum of 3 quarters · filed 2019-03-12 | $269.00K 10-K · filed 2019-03-12 |
| 2016-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $214.00K derived: sum of 2 quarters · filed 2017-11-09 | $243.00K 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $208.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $237.00K 10-Q · filed 2017-08-07 | ||
| 2016-03-31 | $29.00K 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | $5.00K 10-K · filed 2018-03-16 |